Radiodermatitis Clinical Trial
Official title:
Evaluation of Therapeutic Efficacy in Use of Chamomila Gel, Chamomila Infuse and Urea in Patients With Breast or Head and Neck Cancer That Developed Radiodermatitis
This study aims to evaluate therapeutics interventions in radiodermatitis in patients with breast or head and neck cancer. The data collect is going to begin after determining the better dose in a dose-response curve that is being conduct now in the same institution. To evaluate the skin reaction will be applied scale of the Radiation Therapy Oncology Group (RTOG) - Acute Radiation Morbidity Scoring Criteria, Common Terminology Criteria for Adverse Events (CTCAE) and Radiation-Induced Skin Reaction Assessment Scale (RISRAS).
Hypothesis:
Chamomila gel is more effective than urea (usual care); Chamomila infuse is more effective
than urea (usual care); Chamomila gel is more effective than chamomila infuse; Chamomila
infuse is more effective than chamomila gel; Chamomila gel is as effective than urea (usual
care); Chamomila infuse is as effective than urea (usual care); Chamomila gel is as
effective than chamomila infuse; Chamomila infuse is as effective than chamomila gel.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04059809 -
Photobiomodulation for Breast Cancer Radiodermatitis
|
Phase 2/Phase 3 | |
| Withdrawn |
NCT04593914 -
A Novel Skin Barrier Protectant for Acute Radiodermatitis
|
N/A | |
| Completed |
NCT06133218 -
Patient Reported Outcomes Using Mepitel Film During Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT02289365 -
Orally Administrated JBM-TC4 Prevents Acute Radiodermatitis in Breast Cancer Patients
|
Phase 2 | |
| Completed |
NCT04483856 -
Efficacy and Tolerability Evaluation of a Topical MD Based on SHBF in Management of Radiodermatitis.
|
N/A | |
| Completed |
NCT02922244 -
Effects of Herbal Products on Reduction of Radiation-induced Dermatitis in Breast Cancer Patients
|
N/A | |
| Recruiting |
NCT05886673 -
Development of a Protective Cream Against Radiodermatitis Caused by Radiotherapy.
|
N/A | |
| Withdrawn |
NCT01544504 -
Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy
|
Phase 1/Phase 2 | |
| Completed |
NCT03255980 -
Monocenter, Open Label Clinical Investigation on the Treatment of Radiation Induced Dermatitis With Xonrid®
|
N/A | |
| Not yet recruiting |
NCT03557983 -
Evaluation of Fenofibrate on Radiation-induced Skin Injury
|
N/A | |
| Completed |
NCT02247830 -
Management Radiodermatitis in Patients With Breast or Head and Neck Cancer
|
Phase 3 | |
| Terminated |
NCT01367990 -
Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy
|
Phase 1 | |
| Completed |
NCT03924011 -
Photobiomodulation Therapy for the Prevention of Acute Radiodermatitis in Breast Cancer Patients Undergoing Radiotherapy
|
N/A | |
| Terminated |
NCT01263366 -
Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients
|
Phase 1 | |
| Not yet recruiting |
NCT04617730 -
Efficacy of the Mepitel® Film on the Prevention of Radiodermatitis in the Inguinal Fold.
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05535452 -
Photobiomodulation for Prevention of Radiodermatitis in Women With Breast Cancer Undergoing Adjuvant Radiotherapy
|
N/A | |
| Completed |
NCT04239560 -
Preventive Effect of Boron-based Gel on Radiation Dermatitis
|
Phase 3 | |
| Completed |
NCT02249884 -
Dose-Response Curve: Interventions to Prevent and Treat Radiodermatitis
|
Phase 2 | |
| Withdrawn |
NCT04692389 -
Jalosome® Soothing Gel Efficacy Grade 2 or 3 Radiodermatitis.
|
N/A | |
| Enrolling by invitation |
NCT04067310 -
Study Using Spray Skin Protector Versus Conventional Treatment to Prevent Acute Radiodermatitis.
|
N/A |